MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer.
Powles T, Eder JP, Fine GD, Braiteh FS, Loriot Y, Cruz C, Bellmunt J, Burris HA, Petrylak DP, Teng SL, Shen X, Boyd Z, Hegde PS, Chen DS, Vogelzang NJ.
Powles T, et al. Among authors: teng sl.
Nature. 2014 Nov 27;515(7528):558-62. doi: 10.1038/nature13904.
Nature. 2014.
PMID: 25428503
Clinical Trial.